About Calliditas Therapeutics
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas’ lead product, developed under the name Nefecon, has received full approval by the FDA under the trade name TARPEYO® and by the European Commission under the trade name KINPEYGO®. TARPEYOKINPEYGO® is the first treatment approved for IgA nephropathy by the FDA and EMA, respectively.
Calliditas also has a pipeline to address a variety of diseases, including primary biliary cholangitis (PBC), idiopathic pulmonary fibrosis (IPF), Alport Syndrome and solid tumors (SCCHN).
In 2024, Calliditas Therapeutics was acquired by Asahi Kasei.
Position summary
The Rare Disease Account Manager is responsible for developing and implementing a businesssales plan for maximizing net sales of product(s) that is aligned with the direction from commercial leadership and with all company guidelines, policies, and directives. The Rare Disease Account Manager will conduct businesssales with key targeted specialist healthcare providers.
This position reports into the Regional Business Director of the designated territory.
Key tasks and responsibilities
Education and experience requirements
Reasons to join the Calliditas Team
Welcome to join the Calliditas Team!
Calliditas provides equal employment opportunities to all employees and job applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, pregnancy or any other legally protected status. For a copy of the Affirmative Action Plan and EEO Statement, contact hr@calliditas.com.
ServiceNow
ServiceNow
Spartech LLC
FORWARD Platform
Authenticx